2022 annual financial data
Axsome Therapeutics 2022 Operating margin
Direct answer
Operating margin was -359.33%.
Operating income was -179,799,000 USD and net income was -187,134,000 USD.
Operating cash flow was -116,511,000 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,037,000 USD
- Operating income
- -179,799,000 USD
- Net income
- -187,134,000 USD
- Operating cash flow
- -116,511,000 USD